1-[4-[4-[[6-amino-8-(5-fluoro-3-pyridinyl)-2-methylpurin-9-yl]methyl]phenyl]piperidin-1-yl]-2-(dimethylamino)ethanone;8-(5-fluoro-3-pyridinyl)-2-methyl-9-[(4-piperidin-4-ylphenyl)methyl]purin-6-amine;2,2,2-trifluoroacetic acid
C52H56F5N15O3 — CID 161113366
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[4-[[6-amino-8-(5-fluoro-3-pyridinyl)-2-methylpurin-9-yl]methyl]phenyl]piperidin-1-yl]-2-(dimethylamino)ethanone;8-(5-fluoro-3-pyridinyl)-2-methyl-9-[(4-piperidin-4-ylphenyl)methyl]purin-6-amine;2,2,2-trifluoroacetic acid
1-[4-[4-[[6-amino-8-(5-fluoro-3-pyridinyl)-2-methylpurin-9-yl]methyl]phenyl]piperidin-1-yl]-2-(dimethylamino)ethanone;8-(5-fluoro-3-pyridinyl)-2-methyl-9-[(4-piperidin-4-ylphenyl)methyl]purin-6-amine;2,2,2-trifluoroacetic acid (PubChem CID 161113366) has the molecular formula C52H56F5N15O3 and a molecular weight of 1034.11 g/mol. Its IUPAC name is 1-[4-[4-[[6-amino-8-(5-fluoro-3-pyridinyl)-2-methylpurin-9-yl]methyl]phenyl]piperidin-1-yl]-2-(dimethylamino)ethanone;8-(5-fluoro-3-pyridinyl)-2-methyl-9-[(4-piperidin-4-ylphenyl)methyl]purin-6-amine;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | 1-[4-[4-[[6-amino-8-(5-fluoro-3-pyridinyl)-2-methylpurin-9-yl]methyl]phenyl]piperidin-1-yl]-2-(dimethylamino)ethanone;8-(5-fluoro-3-pyridinyl)-2-methyl-9-[(4-piperidin-4-ylphenyl)methyl]purin-6-amine;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 161113366 |
| Molecular Formula | C52H56F5N15O3 |
| Molecular Weight | 1034.11 g/mol |
| Exact Mass | 1033.46 |
| IUPAC Name | 1-[4-[4-[[6-amino-8-(5-fluoro-3-pyridinyl)-2-methylpurin-9-yl]methyl]phenyl]piperidin-1-yl]-2-(dimethylamino)ethanone;8-(5-fluoro-3-pyridinyl)-2-methyl-9-[(4-piperidin-4-ylphenyl)methyl]purin-6-amine;2,2,2-trifluoroacetic acid |
| SMILES | Cc1nc(N)c2nc(-c3cncc(F)c3)n(Cc3ccc(C4CCN(C(=O)CN(C)C)CC4)cc3)c2n1.Cc1nc(N)c2nc(-c3cncc(F)c3)n(Cc3ccc(C4CCNCC4)cc3)c2n1.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C27H31FN8O.C23H24FN7.C2HF3O2/c1-17-31-25(29)24-27(32-17)36(26(33-24)21-12-22(28)14-30-13-21)15-18-4-6-19(7-5-18)20-8-10-35(11-9-20)23(37)16-34(2)3;1-14-28-21(25)20-23(29-14)31(22(30-20)18-10-19(24)12-27-11-18)13-15-2-4-16(5-3-15)17-6-8-26-9-7-17;3-2(4,5)1(6)7/h4-7,12-14,20H,8-11,15-16H2,1-3H3,(H2,29,31,32);2-5,10-12,17,26H,6-9,13H2,1H3,(H2,25,28,29);(H,6,7) |
| InChIKey | FSTNNECBOAPDSD-UHFFFAOYSA-N |
| XLogP | 7.30 |
| TPSA | 237.90 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 75 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1034.11 |
| LogP ≤ 5 | 7.30 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 16 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161113366 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.